title: Influence of dialysate on gastric emptying time in peritoneal dialysis patients.
abstract: OBJECTIVE
  Peritoneal dialysis (PD) patients frequently suffer from dyspeptic complaints such as nausea, vomiting, abdominal distension, early satiety, and anorexia. Gastroparesis might be, at least partially, a source of dyspeptic complaints in PD patients. The aim of the present study was to determine the influence of the presence and composition of dialysate on gastric emptying in PD patients.
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  Renal Division, Department of Internal Medicine, Ghent University Hospital, Belgium.
  
  
  METHODS
  Sixty-one PD patients using different dialysate solutions, and 27 healthy volunteers.
  
  
  METHODS
  Gastric emptying of solids was assessed by the 13C-octanoic acid breath test.
  
  
  RESULTS
  Gastric emptying was impaired in PD patients, regardless of the composition of dialysate and even if tested with an empty peritoneal cavity. Gastric emptying was significantly slower when glucose-containing dialysate was compared to an empty peritoneal cavity, or when glucose-containing dialysate was compared to icodextrin dialysate. No difference in gastric emptying could be demonstrated between glucose-containing dialysate and dialysate containing a mixture of glycerol and amino acids as osmotic agent.
  
  
  CONCLUSIONS
  These findings suggest that the delay in gastric emptying demonstrated in the presence of peritoneal dialysate is not the consequence of a mere volume or pressure effect, but of the absorption of substrate substances with caloric and/or metabolic activity, such as glucose or glycerol and amino acids.
authors.affiliation: Department of Internal Medicine, Ghent University Hospital, Belgium. bruno.vanvlem@rug.ac.be
authors.forename: VlemBrunoA
authors.initials: V
authors.lastname: Van
authors.forename: Renaat S
authors.initials: RS
authors.lastname: Schoonjans
authors.forename: Dirk G
authors.initials: DG
authors.lastname: Struijk
authors.forename: Johan J
authors.initials: JJ
authors.lastname: Verbanck
authors.forename: Raymond C
authors.initials: RC
authors.lastname: Vanholder
authors.forename: BiesenWimV
authors.initials: B
authors.lastname: Van
authors.forename: Romain A
authors.initials: RA
authors.lastname: Lefebvre
authors.forename: VosMartineP
authors.initials: V
authors.lastname: De
authors.forename: Norbert H
authors.initials: NH
authors.lastname: Lameire
mesh_terms: D000328:Adult; D015992:Body Mass Index; D001944:Breath Tests; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology*; D015314:Dialysis Solutions / Q000009:adverse effects* / Q000737:chemistry; D005746:Gastric Emptying / Q000187:drug effects*; D018589:Gastroparesis / Q000209:etiology* / Q000503:physiopathology; D005947:Glucose / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010530:Peritoneal Dialysis; D011446:Prospective Studies
chemical_list: D015314:Dialysis Solutions; D005947:Glucose